Pacific Capital Partners LTD Boston Scientific Corp Transaction History

Pacific Capital Partners LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 May 08, 2025	BUY	$83.62 - $91.5 $1.1 Million - $1.2 Million	13,156 New	13,156 $1.18 Billion
Q3 2024 May 08, 2025	BUY	$72.96 - $84.0 $959,861 - $1.11 Million	13,156 New	13,156 $1.1 Billion
Q2 2024 May 08, 2025	SELL	$67.33 - $77.71 $342,575 - $395,388	-5,088 Reduced 27.89%	13,156 $1.01 Million
Q4 2023 May 08, 2025	BUY	$48.64 - $57.81 $16,099 - $19,135	331 Added 1.85%	18,244 $1.05 Billion
Q3 2023 May 08, 2025	BUY	$50.19 - $54.68 $899,053 - $979,482	17,913 New	17,913 $946 Million

1,832

1.21B

9.66M

6.98M

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $149B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

Get notified when there are updates to the investment portfolio of Pacific Capital Partners LTD, based on Form 13F filings with the SEC.

Stay updated on Pacific Capital Partners LTD with notifications on news.